Congratulations to Dr. Styliani Karanika, who is a JHU TRAC ESI, Mentee, and Developmental Awardee on this publication in the Journal of Clinical Investigation! The open-access full article is available here and the full citation is listed below.
Karanika S, Wang T, Yilma A, Ruelas Castillo J, Gordy JT, Bailey H, Quijada D, Fessler K, Tasneen R, Rouse Salcido EM, Shamma F, Harris HT, Chen F, Bates RE, Ton H, Meza J, Li Y, Taylor AD, Zheng JJ, Zhang J, Karantanos T, Maxwell AR, Nuermberger EL, Peske JD, Markham RB, Karakousis PC. Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models. J Clin Invest. 2026 Feb 3:e196648. doi: 10.1172/JCI196648. Epub ahead of print. PMID: 41632540.